Cancer Vaccines
Geron Ranked in Biotechnology Patent Scorecard Published in the Wall Street Journal
Published in Vaccine Weekly, February 27th, 2008
The ranking, which is based on the strength of Geron's science as measured by the scale, quality, impact and nearness to the core science of the company's intellectual property portfolio, reflects Geron's dominant patent position in pioneering technologies including an anti-cancer drug and vaccine targeting telomerase and cell therapies being developed from the company's human embryonic stem cell platform. Geron owns or licenses 34 issued U.S. patents, over 60 issued foreign patents and more than 230...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-02-27)
More Articles from Vaccine Weekly
- Leukemia Gene Therapy
Gene therapy protocol at UCSD activates immune system in patients with leukemia - Chlamydia
New chlamydia research from D. Heuer et al outlined - Cysticercosis
Research from H. Mayta and co-researchers yields new findings on cysticercosis - DNA Vaccines
Researchers at Johns Hopkins University, Medical Department target DNA vaccines - Falciparum Malaria
New falciparum malaria findings from J.E. Mccoubrie and co-researchers published - Falciparum Malaria
New falciparum malaria study results reported from K. Miura et al - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
